NEWTON INVESTMENT MANAGEMENT
Newton Investment Management is a London-based, global investment management subsidiary of BNY Mellon. We provide investment products and services to a broad range of clients. Assets under management*: £51.8bn (as at 30 June 2016) Head office: London North American office: New York Client base: institutional investors, charities, corporations and, via BNY Mellon, individuals
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-09 | Aspen Neuroscience | Newton Investment Management investment in Series B - Aspen Neuroscience | 147.5 M USD |
| 2022-03-10 | Roofstock | Newton Investment Management investment in Series E - Roofstock | 240 M USD |
| 2019-09-24 | Amphivena Therapeutics | Newton Investment Management investment in Series C - Amphivena Therapeutics | 62 M USD |